Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US6797276B1 · kind B1 · utility
89Cited by
219References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 1999 |
| Grant date | Sep 28, 2004 |
| Priority date | — |
| Expiry date | Feb 25, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transcutaneous immunization system where the topical application of an adjuvant and an antigen or nucleic acid encoding for an antigen, to intact skin induces a ystemic or mucosol antibody response. The immune response so elicited can be enhanced by physical or chemical skin penetration enhancement.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.